CYTORI THERAPEUTICS, INC. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Development Agreements (1 contract)
- Distribution Agreements (4)
- Indemnification Agreements (1)
- Sales Agreements (1)
- Services Agreements (2)
- Settlement Agreements (1)
- Distribution Agreement, dated September 9, 2022, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (Filed With SEC on September 9, 2022)
- Medidata Services Agreement and Statement of Work (Filed With SEC on April 21, 2022)
- Distribution Agreement, dated January 14, 2022, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (Filed With SEC on January 14, 2022)
- Master Services Agreement between Piramal Pharma Solutions, Inc. and Plus Therapeutics, Inc (Filed With SEC on February 22, 2021)
- Distribution Agreement, dated October 23, 2020, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (Filed With SEC on October 23, 2020)
- Form of Indemnification Agreement (Filed With SEC on February 6, 2020)
- Sales Agreement, dated June 1, 2018, by and between Cytori Therapeutics, Inc. and B. Riley FBR, Inc (Filed With SEC on June 1, 2018)
- AMENDMENTONE TO LICENCE/JOINT DEVELOPMENT AGREEMENT (Filed With SEC on August 11, 2008)
- AIA Document ###-###-####, GeneralConditions of the Contract for Construction, is adopted in this document byreference. This document has been approved and endorsed by the... (Filed With SEC on March 30, 2006)
- SETTLEMENT AGREEMENT (Filed With SEC on November 14, 2005)
